FARN — Faron Pharmaceuticals Oy Cashflow Statement
0.000.00%
Last trade - 00:00- £52.57m
- £63.24m
Annual cashflow statement for Faron Pharmaceuticals Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -21.2 | -28.7 | -30.9 | -25.9 | -27.3 |
| Depreciation | |||||
| Non-Cash Items | 0.485 | 1.65 | 4.88 | 8.3 | 8.81 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.82 | 3.79 | 1.91 | -5.67 | 0.199 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -22.2 | -23 | -23.8 | -23 | -17.9 |
| Capital Expenditures | -0.474 | -0.385 | -0.123 | -0.226 | -0.222 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.001 | — | — | — | 0.202 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.473 | -0.385 | -0.123 | -0.226 | -0.02 |
| Financing Cash Flow Items | -0.318 | -0.135 | -1.11 | -5.7 | -7.45 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 25.6 | 23.5 | 24 | 25.8 | 20.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.75 | 0.137 | -0.114 | 2.63 | 2.81 |